HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,682,000 | -1.0% | 292,933 | -0.2% | 0.01% | 0.0% |
| Q4 2021 | $11,804,000 | +3.9% | 293,558 | +5.1% | 0.01% | 0.0% |
| Q3 2021 | $11,363,000 | -9.2% | 279,325 | +1.4% | 0.01% | -14.3% |
| Q2 2021 | $12,514,000 | -8.6% | 275,573 | -16.1% | 0.01% | -12.5% |
| Q1 2021 | $13,692,000 | +12.5% | 328,421 | +15.3% | 0.01% | 0.0% |
| Q4 2020 | $12,170,000 | +62.1% | 284,954 | -0.3% | 0.01% | +60.0% |
| Q3 2020 | $7,509,000 | +4.2% | 285,716 | +6.3% | 0.01% | -16.7% |
| Q2 2020 | $7,208,000 | +99.9% | 268,873 | +34.2% | 0.01% | +100.0% |
| Q1 2020 | $3,605,000 | -20.4% | 200,412 | -21.6% | 0.00% | 0.0% |
| Q4 2019 | $4,531,000 | +26.8% | 255,533 | +10.9% | 0.00% | 0.0% |
| Q3 2019 | $3,574,000 | +47.4% | 230,406 | +63.3% | 0.00% | +50.0% |
| Q2 2019 | $2,425,000 | +60.4% | 141,131 | +50.2% | 0.00% | +100.0% |
| Q1 2019 | $1,512,000 | +26.3% | 93,940 | +14.9% | 0.00% | 0.0% |
| Q4 2018 | $1,197,000 | +75.5% | 81,793 | +117.8% | 0.00% | 0.0% |
| Q3 2018 | $682,000 | -26.8% | 37,552 | -32.0% | 0.00% | 0.0% |
| Q2 2018 | $932,000 | -33.9% | 55,234 | -23.2% | 0.00% | 0.0% |
| Q1 2018 | $1,409,000 | -34.5% | 71,900 | -32.3% | 0.00% | -50.0% |
| Q4 2017 | $2,151,000 | +36.0% | 106,148 | +16.5% | 0.00% | 0.0% |
| Q3 2017 | $1,582,000 | +124.7% | 91,092 | +65.8% | 0.00% | +100.0% |
| Q2 2017 | $704,000 | +2.9% | 54,934 | +4.1% | 0.00% | 0.0% |
| Q1 2017 | $684,000 | +80.0% | 52,784 | +37.2% | 0.00% | 0.0% |
| Q4 2016 | $380,000 | -12.2% | 38,476 | +7.3% | 0.00% | 0.0% |
| Q3 2016 | $433,000 | +48.8% | 35,861 | +6.3% | 0.00% | – |
| Q2 2016 | $291,000 | -2.3% | 33,732 | +7.1% | 0.00% | – |
| Q1 2016 | $298,000 | -28.0% | 31,482 | +31.8% | 0.00% | -100.0% |
| Q4 2015 | $414,000 | +22.1% | 23,882 | -5.5% | 0.00% | 0.0% |
| Q3 2015 | $339,000 | -43.5% | 25,262 | -4.9% | 0.00% | 0.0% |
| Q2 2015 | $600,000 | +52.7% | 26,557 | -3.5% | 0.00% | 0.0% |
| Q1 2015 | $393,000 | +65.8% | 27,515 | +12.1% | 0.00% | – |
| Q4 2014 | $237,000 | +4.9% | 24,536 | -1.3% | 0.00% | – |
| Q3 2014 | $226,000 | -6.2% | 24,848 | +2.0% | 0.00% | -100.0% |
| Q2 2014 | $241,000 | -24.2% | 24,349 | -2.6% | 0.00% | 0.0% |
| Q1 2014 | $318,000 | -11.4% | 25,008 | +4.5% | 0.00% | 0.0% |
| Q4 2013 | $359,000 | +33.0% | 23,933 | -2.2% | 0.00% | 0.0% |
| Q3 2013 | $270,000 | +50.8% | 24,462 | +8.6% | 0.00% | 0.0% |
| Q2 2013 | $179,000 | – | 22,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |